| Value | ₹18.17 Cr |
|---|
NSE filing, NSE: EVEREADY. Summary written from the filing by ALFA Finder's alert engine.
Eveready Industries India Ltd: key numbers
- Share price
- ₹320.10
- Market cap
- ₹2,327 Cr
- Revenue (annual)
- ₹1,455 Cr
- Net profit (annual)
- ₹171.5 Cr
- P/E (TTM)
- 13.1×Sector 41.2×
- Promoter holding
- 43.60%+0.00% QoQ
- FII holding
- 5.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Eveready Industries India Ltd
All →Eveready Industries India Board Meeting Date
Eveready Industries will hold its Board Meeting on 31 October 2026 to approve unaudited Q2/H1 results. The trading window remains closed until 48 hours post-declaration.
Eveready Industries India Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Eveready Industries India Promoter Buying (Off-Market): ₹10.14 Cr
Eveready Industries' promoter group, Times Horizon Private Limited, acquired 307,400 shares from Bennett Coleman & Company Limited via an off-market inter-se transfer.
- Value
- ₹10.14 Cr
- Promoter stake change
- +0.42%
Eveready Industries India Promoter Buying (Off-Market)
Times Horizon Private Limited and other entities acquired a 0.42% stake in Eveready Industries India Limited through a composite scheme of arrangement.
Eveready Industries India Share Pledge
Vivaya Enterprises Private Limited, a promoter of Eveready Industries, pledged 44,558 equity shares. The transaction value amounts to Rs. 1.56 Crore.
- Value
- ₹1.56 Cr
Eveready Industries India Other Announcement
Eveready Industries India Ltd received an unsolicited ESG score of 58 from CRISIL ESG Ratings based on public domain information.
Other financial results announcements
All →Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY
Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹8.1 Cr · +92.9% YoY
STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows
STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.
- Key figure
- Net loss ₹16.1 Cr
RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY
RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹28.2 Cr · -23.6% YoY
Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY
Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.
- Key figure
- Net profit ₹26.6 Cr · +51.1% YoY
Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY
Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹1,532 Cr · +71.8% YoY
Bandaram Pharma Packtech Q2 FY27 Results: Net Profit ₹0.2 Cr, Up 100.0% YoY
Bandaram Pharma Packtech reported audited standalone and consolidated results for the quarter and half-year ended 30.09.2026. Consolidated revenue from operations for the half-year was Rs 4,540.28 lakhs.
- Key figure
- Net profit ₹0.2 Cr · +100.0% YoY